Insiders Selling Nasdaq, Bristol-Myers Squibb And This Consumer Defensive Stock
The Nasdaq Composite dropped by around 150 points on Thursday. Investors, meanwhile, focused on some notable insider trades.
Alphabet And 3 Other Stocks Insiders Are Selling
U.S. crude oil futures traded lower this morning. Investors, meanwhile, focused on some notable insider trades.
How Roxe Uses The Blockchain To Lower Cost And Transaction Times In Cross-Border Remittance
Benzinga is hosting a two-day crypto event at New York City’s Pier Sixty, Dec. 7-8, 2022.
Credit Suisse Maintains Outperform on Nasdaq, Lowers Price Target to $66
Credit Suisse analyst Gautam Sawant maintains Nasdaq (NASDAQ:NDAQ) with a Outperform and lowers the price target from $67.33 to $66.
Kevin O’Leary-Backed WonderFi Buys Blockchain Foundry, Bolsters Web3 Capabilities
WonderFi Technoloies Inc. (OTCQB: WONDF) agreed to acquire Blockchain Foundry Inc. (OTCPK: BLFDF), a blockchain development firm
Morgan Stanley Maintains Overweight on Nasdaq, Raises Price Target to $68
Morgan Stanley analyst Michael Cyprys maintains Nasdaq (NASDAQ:NDAQ) with a Overweight and raises the price target from $67 to $68.
OM Group Makes Hostile Takeover Bid For LSE 22 Years Ago Today
Each day, Benzinga takes a look back at a notable market-related moment that occurred on this date.
What Happened?
On this day in 2000, Swedish company OM Group made a $1.2-billion hostile takeover bid for the London Stock Exchange.
Nasdaq Says Trading Will Remain Halted Until Statera Biopharma Has Fully Satisfied Nasdaq’s Request For Additional Information
The Nasdaq Stock Market® (NASDAQ:NDAQ) announced that trading was halted today in Statera Biopharma, Inc. (NASDAQ:STAB) at 11:01:52 A.M. Eastern Time for "additional information requested" from the
Deutsche Bank Maintains Buy on Nasdaq, Raises Price Target to $205
Deutsche Bank analyst Brian Bedell maintains Nasdaq (NASDAQ:NDAQ) with a Buy and raises the price target from $188 to $205.